SCHEMBL1270519

SCHEMBL1270519

O=C(O)c1ccccc1Oc1ccccc1O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.65
KDM4E B2RXH2 9/20 0.62
ALDH1A1 P00352 7/20 0.62
HPGD P15428 6/20 0.62
HSD17B10 Q99714 6/20 0.62
HMGB1 P09429 2/20 0.59
NAPRT Q6XQN6 2/20 0.59
CA12 O43570 1/20 0.59
CA1 P00915 1/20 0.59
CA2 P00918 1/20 0.59
CA4 P22748 1/20 0.59
CA6 P23280 1/20 0.59
CA7 P43166 1/20 0.59
SMN1; SMN2 Q16637 1/20 0.59
CA9 Q16790 1/20 0.59
CA14 Q9ULX7 1/20 0.59
ESR1 P03372 1/20 0.53
ITGB3 P05106 1/20 0.53
ITGA2B P08514 1/20 0.53
TSHR P16473 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL446113 0.89 HTT (0.77) HTTKDM4EALDH1A1HPGDHSD17B10
SCHEMBL29682980 0.89 HTT (0.77) HTTKDM4EALDH1A1HPGDHSD17B10
SCHEMBL29839667 0.87 HTT (0.81) HTTKDM4EALDH1A1HPGDHSD17B10
SCHEMBL8434168 0.87 HTT (0.81) HTTKDM4EALDH1A1HPGDHSD17B10
Hydrochloric Acid SCHEMBL9633469 0.87 HTT (0.74) HTTKDM4EALDH1A1HPGDHSD17B10
SCHEMBL9251939 0.87 ALDH1A1 (0.53) HTTKDM4EALDH1A1HPGDHSD17B10
Anthranilic Acid SCHEMBL2579669 0.85 ALDH1A1 (0.52) HTTKDM4EALDH1A1HPGDHSD17B10
Ethylene SCHEMBL8620063 0.85 HTT (0.71) HTTKDM4EALDH1A1HPGDHSD17B10
SCHEMBL12217892 0.84 G6PD (0.62) HTTKDM4EALDH1A1HPGDHSD17B10
SCHEMBL11033915 0.84 HTT (0.60) HTTKDM4EALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7196214-B2 Process for arylamine production XEROX CORPORATION (US) 2007-03-27 US claimed
US-20060111582-A1 Process for arylamine production XEROX CORPORATION (US) 2006-05-25 US claimed
JP-5208937-A None JP disclosed
JP-55133423-A None JP disclosed
WO-2025095045-A1 TRANSPARENT RESIN COMPOSITION, DRY FILM, CURED PRODUCT, AND ELECTRONIC COMPONENT 太陽ホールディングス株式会社 2025-05-08 WO disclosed
WO-2025095046-A1 RESIN COMPOSITION, DRY FILM, CURED PRODUCT, AND LIGHT EMITTING ELEMENT MOUNTED SUBSTRATE 太陽ホールディングス株式会社 2025-05-08 WO disclosed
CN-119278225-A Curable resin, curable resin intermediate, curable resin composition, and method for producing cured product 株式会社日本触媒 2025-01-07 CN disclosed
WO-2024009612-A1 CURABLE RESIN, AND METHODS FOR MANUFACTURING CURABLE RESIN INTERMEDIATE, CURABLE RESIN, CURABLE RESIN COMPOSITION, AND CURED PRODUCT 株式会社日本触媒 2024-01-11 WO disclosed
US-20230324789-A1 PHOTOSENSITIVE RESIN COMPOSITION, PERMANENT RESIST, METHOD FOR FORMING PERMANENT RESIST, AND METHOD FOR INSPECTING PERMANENT RESIST CURED FILM RESONAC CORPORATION (JP) 2023-10-12 US disclosed
CN-116194840-A Photosensitive resin composition, permanent resist, method for forming permanent resist, and method for inspecting cured film for permanent resist 株式会社力森诺科 2023-05-30 CN disclosed
WO-2023281584-A1 PHOTOSENSITIVE RESIN COMPOSITION, PERMANENT RESIST, METHOD FOR FORMING PERMANENT RESIST, AND METHOD FOR INSPECTING PERMANENT RESIST CURED FILM 昭和電工マテリアルズ株式会社 2023-01-12 WO disclosed
US-6077879-A RADICALLY POLYMERIZABLE CURABLE RESIN OBTAINED BY REACTING POLYEPOXIDE WITH PHENOL COMPOUND HAVING ALCOHOLIC HYDROXYL GROUP AND UNSATURATED MONOBASIC ACID NIPPON SHOKUBAI CO., LTD. (JP) 2000-06-20 US disclosed
EP-0442748-B1 Improvements in and relating to leukotriene antagonists LILLY CO ELI (US) 1995-01-11 EP disclosed
JP-H05208937-A PRODUCTION OF ALKOXYPHENOXY BENZOATE AND ITS USE IN PRODUCTION OF HYDROXY-PHENOXY BENZOIC ACID ELF ATOCHEM SA 1993-08-20 JP disclosed
EP-0521796-A1 Process for the preparation of esters of alkoxyphenoxybenzoic acids and their use in the preparation of hydroxyphenoxybenzoic acids ELF ATOCHEM S.A. (FR) 1993-01-07 EP disclosed
EP-0521796-A1 Process for the preparation of esters of alkoxyphenoxybenzoic acids and their use in the preparation of hydroxyphenoxybenzoic acids ELF ATOCHEM S.A. (FR) 1993-01-07 EP disclosed
EP-0442748-A1 Improvements in and relating to leukotriene antagonists ELI LILLY AND COMPANY (US) 1991-08-21 EP disclosed
US-4996230-A Antiallergens, antiinflammatory agent ELI LILLY AND COMPANY (US) 1991-02-26 US disclosed
US-4459306-A ANTIDEPRESSANTS, SEDATIVES SCIENCE UNION ET CIE (FR) 1984-07-10 US disclosed
JP-S55133423-A NOVEL AND USEFUL AROMATIC POLYESTER AND ITS PREPARATION HITACHI CHEM CO LTD 1980-10-17 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060111582-A1 Process for arylamine production AOC2, UFM1, TYR HTT 792/4885KDM4E 956/4885ALDH1A1 1029/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.